Sherbrooke and Eastern
Type of Organization
Field of Activity
Cancer / Oncology / Hematology
Paladin has emerged as one of Canada's leading specialty pharmaceutical companies. Since our inception in 1996, our revenues have grown at a compounded annual growth rate of 111% and our profitability has ranked us among Canada's most profitable publicly traded pharmaceutical companies. Our growth is fostered by the relentless execution of our strategy of acquiring and in-licensing innovative pharmaceuticals for the Canadian market.
Our mission is to be the leader in specialty pharmaceutical innovation. We will make a positive impact on the lives of patients.
Paladin's strategy is to leverage its strong sales and marketing capabilities with the acquisition and in-licensing of complementary products. Continued growth will be fueled by the launch of innovative products - principally sourced from small to medium sized pharmaceutical and biotechnology companies with promising technology but no sales and marketing capabilities in Canada.